R E Vanderlinde

831 total citations
34 papers, 521 citations indexed

About

R E Vanderlinde is a scholar working on Clinical Biochemistry, Biochemistry and Molecular Biology. According to data from OpenAlex, R E Vanderlinde has authored 34 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 10 papers in Biochemistry and 9 papers in Molecular Biology. Recurrent topics in R E Vanderlinde's work include Metabolism and Genetic Disorders (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). R E Vanderlinde is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Amino Acid Enzymes and Metabolism (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). R E Vanderlinde collaborates with scholars based in United States and United Kingdom. R E Vanderlinde's co-authors include Robert Rej, S N Buhl, Henry M. Laboda, Jaques Bourdillon, Robert Schaffer, G N Bowers, Frank D. Vasington, Piotr Kowalski, O. Watkins Smith and W.W. Westerfeld and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Endocrinology.

In The Last Decade

R E Vanderlinde

34 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R E Vanderlinde United States 13 129 89 79 68 67 34 521
R N Rand United States 10 204 1.6× 49 0.6× 46 0.6× 124 1.8× 35 0.5× 12 663
Victor M. Rosenoer United Kingdom 14 121 0.9× 51 0.6× 76 1.0× 142 2.1× 28 0.4× 31 664
Theodore W. Esders United States 9 240 1.9× 52 0.6× 40 0.5× 84 1.2× 23 0.3× 10 546
T W Wu United States 11 273 2.1× 42 0.5× 44 0.6× 100 1.5× 33 0.5× 16 660
R. Helger Germany 8 162 1.3× 31 0.3× 36 0.5× 30 0.4× 30 0.4× 20 490
R.-K. Aaran Finland 10 278 2.2× 53 0.6× 55 0.7× 66 1.0× 27 0.4× 12 878
G M Dappen France 7 160 1.2× 35 0.4× 30 0.4× 94 1.4× 21 0.3× 10 528
M. Thévenin France 11 105 0.8× 44 0.5× 43 0.5× 51 0.8× 52 0.8× 38 611
B W Perry United States 10 211 1.6× 23 0.3× 61 0.8× 44 0.6× 60 0.9× 15 598
Henry K.J. Hahn United States 11 110 0.9× 24 0.3× 43 0.5× 57 0.8× 39 0.6× 18 646

Countries citing papers authored by R E Vanderlinde

Since Specialization
Citations

This map shows the geographic impact of R E Vanderlinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Vanderlinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Vanderlinde more than expected).

Fields of papers citing papers by R E Vanderlinde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E Vanderlinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Vanderlinde. The network helps show where R E Vanderlinde may publish in the future.

Co-authorship network of co-authors of R E Vanderlinde

This figure shows the co-authorship network connecting the top 25 collaborators of R E Vanderlinde. A scholar is included among the top collaborators of R E Vanderlinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E Vanderlinde. R E Vanderlinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spielvogel, Richard L., et al.. (1992). Serum androstanediol glucuronide in women with facial hirsutism. Journal of the American Academy of Dermatology. 26(3). 411–414. 6 indexed citations
2.
Schwartz, Allan B., et al.. (1990). Heparin Free Hemodialysis Does Not Cause Fibrin Consumptive Coagulopathy and Maintains Alternate Pathway Complement Activation. ASAIO Transactions. 36(2). 86–89. 2 indexed citations
3.
Duncan, P H, Nathan Gochman, D D Bayse, et al.. (1982). A candidate reference method for uric acid in serum. II. Interlaboratory testing.. Clinical Chemistry. 28(2). 291–293. 10 indexed citations
4.
Vanderlinde, R E. (1981). Urinary enzyme measurements in the diagnosis of renal disorders.. PubMed. 11(3). 189–201. 54 indexed citations
5.
Buhl, S N, Piotr Kowalski, & R E Vanderlinde. (1978). Quantitative toxicology: interlaboratory and intermethod evaluation in New York State.. Clinical Chemistry. 24(3). 442–447. 2 indexed citations
6.
Buhl, S N, et al.. (1977). The effect of temperature on the kinetic constants of human lactate dehydrogenase 1 and 5. Clinica Chimica Acta. 80(2). 265–270. 6 indexed citations
7.
8.
Buhl, S N, et al.. (1976). A search for the best buffer to use in assaying human lactate dehydrogenase with the lactate-to-pyruvate reaction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(11). 1872–5. 9 indexed citations
9.
Buhl, S N, et al.. (1976). A search for the best buffer to use in assaying human lactate dehydrogenase with the lactate-to-pyruvate reaction.. Clinical Chemistry. 22(11). 1872–1875. 10 indexed citations
10.
Rej, Robert, et al.. (1975). Interlaboratory Proficiency, Intermethod Comparison, and Calibrator Suitability in Assay of Serum Aspartate Aminotransferase Activity. Clinical Chemistry. 21(8). 1141–1158. 15 indexed citations
11.
Rej, Robert & R E Vanderlinde. (1975). Effects of Buffers on Aspartate Aminotransferase Activity and Association of the Enzyme with Pyridoxal Phosphate. Clinical Chemistry. 21(11). 1585–1591. 30 indexed citations
12.
Vanderlinde, R E, et al.. (1975). Linearity and accuracy of ultraviolet and visible wavelength photometers: An interlaboratory survey. Clinica Chimica Acta. 61(1). 39–46. 7 indexed citations
13.
Rej, Robert & R E Vanderlinde. (1974). The lack of L-thyroxine inhibition of human aspartate aminotransferases. Clinical Biochemistry. 7(1-4). 161–164. 2 indexed citations
14.
Rej, Robert & R E Vanderlinde. (1974). Assay of Aspartate Aminotransferase Activity: Effects of Serum and Serum Proteins on Oxalacetate Decarboxylation and Dialysis. Clinical Chemistry. 20(4). 454–464. 6 indexed citations
15.
Rej, Robert & R E Vanderlinde. (1973). Proficiency testing in acid-base analyses: An interlaboratory evaluation. Clinica Chimica Acta. 49(2). 161–167. 5 indexed citations
16.
Rej, Robert, et al.. (1973). Increased Aspartate Aminotransferase Activity of Serum after in Vitro Supplementation with Pyridoxal Phosphate. Clinical Chemistry. 19(1). 92–98. 51 indexed citations
17.
Rej, Robert, et al.. (1973). A Discussion of Enzyme Reference Materials: Applications and Specifications. Clinical Chemistry. 19(1). 5–9. 55 indexed citations
18.
Vanderlinde, R E, et al.. (1972). Determination of Serum Acid Phosphatase Activity: A Performance Evaluation for Clinical Laboratories of Upstate New York. Clinical Chemistry. 18(2). 131–136. 3 indexed citations
19.
Vasington, Frank D., et al.. (1958). RELATIONSHIP OF LOW PROTEIN DIET AND ASCORBIC ACID IN ESTROGEN INACTIVATION BY LIVER. Endocrinology. 62(5). 557–564. 4 indexed citations
20.
Vanderlinde, R E, Frank D. Vasington, & W.W. Westerfeld. (1955). The Oxidation of Stilbestrol in Alkali1. Journal of the American Chemical Society. 77(15). 4176–4178. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R N Rand Breakdown of academic impact, for papers by Victor M. Rosenoer Breakdown of academic impact, for papers by Theodore W. Esders Breakdown of academic impact, for papers by T W Wu Breakdown of academic impact, for papers by R. Helger Breakdown of academic impact, for papers by R.-K. Aaran Breakdown of academic impact, for papers by G M Dappen Breakdown of academic impact, for papers by M. Thévenin Breakdown of academic impact, for papers by B W Perry Breakdown of academic impact, for papers by Henry K.J. Hahn
Rankless by CCL
2026